Literature DB >> 16084939

Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.

Timothy D Jones1, Kevin M Kernek, Ximing J Yang, Antonio Lopez-Beltran, Gregory T MacLennan, John N Eble, Haiqun Lin, Chong-Xian Pan, Maria Tretiakova, Lee Ann Baldridge, Liang Cheng.   

Abstract

Small cell carcinoma of the urinary bladder is a rare and aggressive tumor resembling small cell carcinoma of the lung. Thyroid transcription factor 1 (TTF-1) expression is common in small cell carcinomas arising in the lung. However, studies of its expression in extrapulmonary small cell carcinomas have yielded varying results. Because information concerning the immunohistochemical profile of small cell carcinoma of the urinary bladder is limited, we investigated the immunoreactivity of this tumor to a battery of antibodies in a series of 44 cases. Using 5-mum sections cut from paraffin-embedded tissue blocks, immunohistochemistry was performed to detect TTF-1, cytokeratin (CK) 7, CK20, and uroplakin antigenicity in 44 cases of small cell carcinoma of the urinary bladder. None of the patients had primary lung tumors. The TTF-1 immunohistochemical stain showed nuclear positivity in 17 cases (39%). Positive immunostaining for CK7 was observed in 26 cases (59%). There was no positive staining with either CK20 or uroplakin. There was no correlation between TTF-1 expression and survival (P = .27). In addition, TTF-1 expression did not correlate with clinicopathological characteristics, including age (P = .74), sex (P = .53), smoking history (P = .96), clinical stage (P = .10), pathological T stage (P = .50), lymph node metastasis (P = .40), and distant metastasis (P = .58). In summary, TTF-1 expression in small cell carcinoma of the urinary bladder was found in 39% of the tumors, demonstrating that this marker is expressed in small cell carcinomas other than those of pulmonary origin. Small cell carcinoma of the urinary bladder is positive for CK7 immunostaining in 59% of cases consistent with its origin from urothelium. Unlike urothelial carcinoma, expression of CK20 and uroplakin in small cell carcinoma of the urinary bladder is consistently negative, and thus, these stains do not appear to be useful in the diagnosis of this neoplasm. TTF-1 positivity is not a significant prognostic factor in small cell carcinoma of the urinary bladder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084939     DOI: 10.1016/j.humpath.2005.04.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  28 in total

1.  Small cell carcinoma of the urinary bladder without gross hematuria: a case report.

Authors:  Wanqiu Huang; Yang Luan; Lu Jin; Tao Wang; Ruibao Chen; Zheng Liu; Zhiqiang Chen; Ruzhu Lan
Journal:  Front Med       Date:  2015-08-13       Impact factor: 4.592

2.  Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

Authors:  Patricia Moretto; Lori Wood; Urban Emmenegger; Normand Blais; Som Dave Mukherjee; Eric Winquist; Eric Charles Belanger; Robert Macrae; Alexander Balogh; Ilias Cagiannos; Wassim Kassouf; Peter Black; Piotr Czaykowski; Joel Gingerich; Scott North; Scott Ernst; Suzanne Richter; Srikala Sridhar; M Neil Reaume; Denis Soulieres; Andrea Eisen; Christina M Canil
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

3.  Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.

Authors:  Ma Jesús Fernández-Aceñero; Sharon Córdova; Félix Manzarbeitia; Camino Medina
Journal:  Pathol Oncol Res       Date:  2011-01-04       Impact factor: 3.201

Review 4.  [Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers].

Authors:  S Reu; J Neumann; T Kirchner
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

5.  TTF-1 positive small cell cancers: Don't think they're always primary pulmonary!

Authors:  Laurine Verset; Marianna Arvanitakis; Patricia Loi; Jean Closset; Myriam Delhaye; Myriam Remmelink; Pieter Demetter
Journal:  World J Gastrointest Oncol       Date:  2011-10-15

6.  Extrapulmonary small cell carcinoma of the liver: clinicopathological and immunohistochemical findings.

Authors:  Suk Jin Choi; Joon Mee Kim; Jee Young Han; Seung Ik Ahn; Jin-Soo Kim; Lucia Kim; In Suh Park; Young Chae Chu
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

7.  Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.

Authors:  Dongfeng Tan; Dani S Zander
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.

Authors:  Soraya Puente; Ana Velasco; Pilar Gallel; Judit Pallares; Luis Perez-Ruiz; Susana Ros; Javier Maravall; Xavier Matias-Guiu
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 9.  Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.

Authors:  David S Priemer; Rodolfo Montironi; Lisha Wang; Sean R Williamson; Antonio Lopez-Beltran; Liang Cheng
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

10.  Outcome of recurrent and metastatic small cell carcinoma of the bladder.

Authors:  Nabil Ismaili; Pierre Etienne Heudel; Fadi Elkarak; Wafaa Kaikani; Agathe Bajard; Mohammed Ismaili; Hassan Errihani; Jean Pierre Droz; Aude Flechon
Journal:  BMC Urol       Date:  2009-06-06       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.